+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bristol-Myers Squibb - logo

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

Proteasome Inhibitors Market Report 2026 - Product Thumbnail Image

Proteasome Inhibitors Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Soft Tissue Sarcoma Market Report 2026 - Product Thumbnail Image

Soft Tissue Sarcoma Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Polymyositis - Pipeline Insight, 2025 - Product Thumbnail Image

Polymyositis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Thematic Intelligence - Biosimilars in oncology - Product Thumbnail Image

Thematic Intelligence - Biosimilars in oncology

  • Report
  • December 2023
  • 76 Pages
  • Global
From
Scientific Research and Development Services Market Report 2026 - Product Thumbnail Image

Scientific Research and Development Services Market Report 2026

  • Report
  • January 2026
  • 250 Pages
  • Global
From
Targeted Therapy Market Report 2026 - Product Thumbnail Image

Targeted Therapy Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
mTOR Inhibitors Market Report 2026 - Product Thumbnail Image

mTOR Inhibitors Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Myeloproliferative Disorders Drugs Market Report 2026 - Product Thumbnail Image

Myeloproliferative Disorders Drugs Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Anthracycline Market Report 2026 - Product Thumbnail Image

Anthracycline Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Pheochromocytoma Market Report 2026 - Product Thumbnail Image

Pheochromocytoma Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Anti-Neoplastic Agents Market Report 2026 - Product Thumbnail Image

Anti-Neoplastic Agents Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Intratumoral Cancer Therapies Market Report 2026 - Product Thumbnail Image

Intratumoral Cancer Therapies Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Solid Tumor Cancer Treatment Market Report 2026 - Product Thumbnail Image

Solid Tumor Cancer Treatment Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Plasma Protease C1 Inhibitor Market 2024-2028 - Product Thumbnail Image

Plasma Protease C1 Inhibitor Market 2024-2028

  • Report
  • January 2024
  • 166 Pages
  • Global
From
Multiple Sclerosis - Pipeline Insight, 2025 - Product Thumbnail Image

Multiple Sclerosis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 180 Pages
  • Global
From
RNA Targeting Small Molecule Drug Discovery Market Report 2026 - Product Thumbnail Image

RNA Targeting Small Molecule Drug Discovery Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Orphan Drugs Market Report 2026 - Product Thumbnail Image

Orphan Drugs Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
NK Cell Therapies - Pipeline Insight, 2025 - Product Thumbnail Image

NK Cell Therapies - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 120 Pages
  • Global
From
Loading Indicator